Brevan Howard Capital Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-172,769
Closed -$496K 1350
2024
Q1
$496K Buy
+172,769
New +$496K ﹤0.01% 421